SPAC Overview
Timeline Progress
About
Therapeutics Acquisition Corp. is a blank-check company seeking an initial business combination, with a stated focus on the healthcare industry and an emphasis on biotechnology. Its proposed business purpose is to acquire an operating business through a merger or similar combination.
Investment Focus
Healthcare, Biopharmaceuticals
Geographic Focus
United States
The terms and the filing trail behind Therapeutics Acquisition Corp.
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Leadership
Underwriters
Extended Team Information
The team is led by RA Capital founder and managing partner Peter Kolchinsky and RA Capital principal Matthew Hammond, with directors experienced in biotech entrepreneurship and operating leadership, biopharmaceutical finance, and biotechnology company executive management. RA Capital is a life-sciences-focused investment firm with extensive healthcare and biotechnology investment experience.